Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. (Q33683126)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. |
scientific article |
Statements
Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer† (English)
A M Gonzalez-Angulo
A Akcakanat
S Liu
M C Green
J L Murray
H Chen
S L Palla
K B Koenig
A M Brewster
V Valero
N K Ibrahim
S Moulder-Thompson
J K Litton
E Tarco
J Moore
P Flores
D Crawford
M J Dryden
W F Symmans
A Sahin
L Pusztai
K-A Do
G N Hortobagyi
F Meric-Bernstam
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference